Use of Open-Flow Microperfusion to Measure LY2605541 and Human Insulin Concentrations in Adipose Tissue Interstitial Fluid
Phase of Trial: Phase I
Latest Information Update: 19 May 2015
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 14 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 02 Apr 2015 Planned End Date changed from 1 Mar 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov.
- 02 Apr 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov.